J Pediatr Infect Dis 2017; 12(04): 222-227
DOI: 10.1055/s-0037-1603496
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Toxocariasis in Children: An Update on Clinical Manifestations, Diagnosis, and Treatment

Nagwa Mostafa El-Sayed
1   Department of Medical Parasitology, Research Institute of Ophthalmology, Giza, Egypt
,
Manar Ezzelarab Ramadan
2   Department of Parasitology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
› Institutsangaben
Weitere Informationen

Publikationsverlauf

21. Januar 2017

09. Februar 2017

Publikationsdatum:
07. Juni 2017 (online)

Abstract

Toxocariasis, a parasitic infection, carries a major health risk in children, especially in the developing countries. Children are the most infected group because of their undeveloped immune system, their higher exposure to infection, and the frequency of reinfections depending on the factors related to their hygienic and behavioral habits. Many human infections are asymptomatic, with only eosinophilia and positive serology. However, several complications were associated with this neglected disease. These complications depend on the organs invaded by migrating Toxocara larvae, the degree of the larvae burden, and the strength of the host immune response. This review aims at giving an update on clinical manifestations, diagnosis, and treatment of toxocariasis in children. The pediatricians should merge this information into their clinical diagnosis to defeat this neglected disease by establishing the correct diagnosis and treatment.

 
  • References

  • 1 Lee RM, Moore LB, Bottazzi ME, Hotez PJ. Toxocariasis in North America: a systematic review. PLoS Negl Trop Dis 2014; 8 (08) e3116
  • 2 Mazur-Melewska K, Mania A, Figlerowicz M, Kemnitz P, Służewski W, Michalak M. The influence of age on a clinical presentation of Toxocara spp. infection in children. Ann Agric Environ Med 2012; 19 (02) 233-236
  • 3 Jarosz W, Mizgajska-Wiktor H, Kirwan P, Konarski J, Rychlicki W, Wawrzyniak G. Developmental age, physical fitness and Toxocara seroprevalence amongst lower-secondary students living in rural areas contaminated with Toxocara eggs. Parasitology 2010; 137 (01) 53-63
  • 4 Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF. Seroepidemiology of Toxocara infection in patients with vision impairment and blindness in durango, Mexico. J Clin Med Res 2015; 7 (03) 176-181
  • 5 Foyaca-Sibat H, Ibañez-Valdés L, Moré-Rodríguez J. Parasitic zoonoses of the brain: Another challenger?. Internet J Neurol 2009; 12 (02) 245-253
  • 6 Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol 2010; 104 (01) 3-23
  • 7 El-Sayed NM, Ismail KA. Relationship between Toxocara canis infection and schizophrenia. Rawal Med J 2012; 37 (02) 155-161
  • 8 Cortés NN, Núñez CR, Guiliana BG, García PA, Heredia R. Presence of anti-Toxocara canis antibodies and risk factors in children from the Amecameca and Chalco regions of México. BMC Pediatr 2015; 15: 65
  • 9 Hoffmeister B, Glaeser S, Flick H, Pornschlegel S, Suttorp N, Bergmann F. Cerebral toxocariasis after consumption of raw duck liver. Am J Trop Med Hyg 2007; 76 (03) 600-602
  • 10 Overgaauw PAM, van Zutphen L, Hoek D. , et al. Zoonotic parasites in fecal samples and fur from dogs and cats in The Netherlands. Vet Parasitol 2009; 163 (1-2): 115-122
  • 11 Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol 2001; 39 (01) 1-11
  • 12 Stoicescu RM, Mihai CM, Giannakopoulou AD. Marked hypereosinophilia in a toddler: a case report. J Med Life 2011; 4 (01) 105-108
  • 13 Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol 2001; 75 (04) 299-305
  • 14 Park S, Kim YS, Kim YJ. , et al. Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases. Dig Dis Sci 2012; 57 (01) 155-160
  • 15 Yoshiji H, Yoshikawa M, Kaji K, Fukui H. Eosinophilic cholecystitis as a rare manifestation of visceral larva migrans. World J Gastroenterol 2007; 13 (45) 6119
  • 16 Guha M, Jariwala S, Jinjolova N. , et al. Toxocariasis presenting as eosinophilic ascites in a post-partum female. J Parasit Dis 2015; 39 (02) 284-286
  • 17 Ghoroobi J, Mohajerzadeh L, Khoddami M. , et al. Abdominal mass secondary to human toxocariasis. APSP J Case Rep 2017; 8 (01) 4
  • 18 Pinelli E, Brandes S, Dormans J, Gremmer E, van Loveren H. Infection with the roundworm Toxocara canis leads to exacerbation of experimental allergic airway inflammation. Clin Exp Allergy 2008; 38 (04) 649-658
  • 19 Ashwath ML, Robinson DR, Katner HP. A presumptive case of toxocariasis associated with eosinophilic pleural effusion: case report and literature review. Am J Trop Med Hyg 2004; 71 (06) 764
  • 20 El-Tantawy NL, El-Nahas HA, El-Assmy MM, Alsalem AM. Clinico-seroepidemiological evaluation of toxocariasis in asthmatic pediatric children in Mansoura city in Egypt. Arch Clin Microbiol 2013; 4: 3
  • 21 Tadié JM, Chaudeurge A, Lerolle N. , et al. Acute respiratory distress syndrome due to Toxocara cati infection [in French]. Rev Mal Respir 2010; 27 (05) 505-508
  • 22 Gavignet B, Piarroux R, Aubin F, Millon L, Humbert P. Cutaneous manifestations of human toxocariasis. J Am Acad Dermatol 2008; 59 (06) 1031-1042
  • 23 Zotos PG, Psimenou E, Roussou M, Kontogiannis S, Panoutsopoulos A, Dimopoulos AM. Nephrotic syndrome as a manifestation of Toxocara canis infection. Nephrol Dial Transplant 2006; 21 (09) 2675-2676
  • 24 Viola GR, Giacomin MF, França CMP, Sallum AM, Jacob CM, Silva CA. Chronic polyarthritis as isolated manifestation of toxocariasis. Rev Bras Reumatol Engl Ed 2016; 56 (02) 185-187
  • 25 Shibazaki S, Eguchi S, Endo T. , et al. Eosinophilic myocarditis due to toxocariasis: Not a rare cause. Case Rep Cardiol 2016; 2016: 2586292
  • 26 Dimayuga E, Stober M, Kayes SG. Eosinophil peroxidase levels in hearts and lungs of mice infected with Toxocara canis. J Parasitol 1991; 77 (03) 461-466
  • 27 Ahn SJ, Ryoo NK, Woo SJ. Ocular toxocariasis: clinical features, diagnosis, treatment, and prevention. Asia Pac Allergy 2014; 4 (03) 134-141
  • 28 Cortez RT, Ramirez G, Collet L, Giuliari GP. Ocular parasitic diseases: a review on toxocariasis and diffuse unilateral subacute neuroretinitis. J Pediatr Ophthalmol Strabismus 2011; 48 (04) 204-212
  • 29 Singh A, Cunningham Jr ET, Stewart JM. Detection and treatment of ocular toxocariasis. Rev Ophthalmol 2007; 14: 55-58
  • 30 Othman AA, Abdel-Aleem GA, Saied EM, Mayah WW, Elatrash AM. Biochemical and immunopathological changes in experimental neurotoxocariasis. Mol Biochem Parasitol 2010; 172 (01) 1-8
  • 31 Holland CV, Hamilton CM. The significance of cerebral toxocariasis: a model system for exploring the link between brain involvement, behaviour and the immune response. J Exp Biol 2013; 216 (Pt 1): 78-83
  • 32 Vidal JE, Sztajnbok J, Seguro AC. Eosinophilic meningoencephalitis due to Toxocara canis: case report and review of the literature. Am J Trop Med Hyg 2003; 69 (03) 341-343
  • 33 Caldera F, Burlone ME, Genchi C, Pirisi M, Bartoli E. Toxocara encephalitis presenting with autonomous nervous system involvement. Infection 2013; 41 (03) 691-694
  • 34 Fan CK, Holland CV, Loxton K, Barghouth U. Cerebral toxocariasis: silent progression to neurodegenerative disorders?. Clin Microbiol Rev 2015; 28 (03) 663-686
  • 35 Walsh MG, Haseeb MA. Reduced cognitive function in children with toxocariasis in a nationally representative sample of the United States. Int J Parasitol 2012; 42 (13-14): 1159-1163
  • 36 Holland CV, Cox DM. Toxocara in the mouse: a model for parasite-altered host behaviour?. J Helminthol 2001; 75 (02) 125-135
  • 37 Moreira-Silva SF, Rodrigues MG, Pimenta JL, Gomes CP, Freire LH, Pereira FE. Toxocariasis of the central nervous system: with report of two cases. Rev Soc Bras Med Trop 2004; 37 (02) 169-174
  • 38 Watthanakupanich D. Diagnostic trends of human toxocariasis. J Trop Med Parasitol 2010; 33: 44-52
  • 39 Nathwani D, Laing RB, Currie PF. Covert toxocariasis--a cause of recurrent abdominal pain in childhood. Br J Clin Pract 1992; 46 (04) 271
  • 40 Smith H, Holland C, Taylor M, Magnaval J-F, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol 2009; 25 (04) 182-188
  • 41 Zibaei M, Sadjjadi SM, Karamian M, Uga S, Oryan A, Jahadi-Hosseini SH. A comparative histopathology, serology and molecular study, on experimental ocular toxocariasis by Toxocara cati in Mongolian gerbils and Wistar rats. BioMed Res Int 2013; 2013: 109580
  • 42 Fillaux J, Magnaval JF. Laboratory diagnosis of human toxocariasis. Vet Parasitol 2013; 193 (04) 327-336
  • 43 Jin Y, Shen C, Huh S, Sohn WM, Choi MH, Hong ST. Serodiagnosis of toxocariasis by ELISA using crude antigen of Toxocara canis larvae. Korean J Parasitol 2013; 51 (04) 433-439
  • 44 Perteguer MJ, Águila C, Fenoy S, Guillén JL, Cuéllar C. Cross-reactivity induced by Anisakis simplex and Toxocara canis in mice. J Helminthol 2003; 77 (04) 331-334
  • 45 Moreira GM, Telmo PdeL, Mendonça M. , et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol 2014; 30 (09) 456-464
  • 46 Uhlíková M, Hübner J, Leissová M. The ocular form of larval toxocariasis in the Czech Republic [in Czech]. Cesk Slov Oftalmol 2002; 58 (02) 75-83
  • 47 Roldán WH, Espinoza YA. Evaluation of an enzyme-linked immunoelectrotransfer blot test for the confirmatory serodiagnosis of human toxocariasis. Mem Inst Oswaldo Cruz 2009; 104 (03) 411-418
  • 48 Petithory JC, Chaumeil C, Liotet S, Rosseau M, Bisognani C. Immunological studies on ocular larva migrans. In: Lewis JW, Maizels RM. , eds. Toxocara and Toxocariasis; Clinical, Epidemiological and Molecular Perspectives. London, UK: The British Society for Parasitology with the Institute of Biology; 1993: 81-89
  • 49 Elefant GR, Shimizu SH, Sanchez MC, Jacob CM, Ferreira AW. A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J Clin Lab Anal 2006; 20 (04) 164-172
  • 50 Fogt-Wyrwas R, Jarosz W, Mizgajska-Wiktor H. Utilizing a polymerase chain reaction method for the detection of Toxocara canis and T. cati eggs in soil. J Helminthol 2007; 81 (01) 75-78
  • 51 Van De N, Trung NV, Duyet V, Chai JY. Molecular diagnosis of an ocular toxocariasis patient in Vietnam. Korean J Parasitol 2013; 51 (05) 563-567
  • 52 Musso C, Castelo JS, Tsanaclis AM, Pereira FE. Prevalence of Toxocara-induced liver granulomas, detected by immunohistochemistry, in a series of autopsies at a Children's Reference Hospital in Vitoria, ES, Brazil. Virchows Arch 2007; 450 (04) 411-417
  • 53 Lim PK, Yamasaki H, Mak JW. , et al. Field evaluation of a rapid diagnostic test to detect antibodies in human toxocariasis. Acta Trop 2015; 148: 32-37
  • 54 Magnaval J-F. Apparent weak efficacy of ivermectin for treatment of human toxocariasis. Antimicrob Agents Chemother 1998; 42 (10) 2770
  • 55 Lopez MdeL, Martin G, Chamorro MdelC, Mario Alonso J. Toxocariasis in children from a subtropical region [in Spanish]. Medicina (B Aires) 2005; 65 (03) 226-230
  • 56 Barrera MG, Leonardi D, Bolmaro RE. , et al. In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans. Eur J Pharm Biopharm 2010; 75 (03) 451-454
  • 57 Musa D, Senocak G, Borazan G. , et al. Effects of Nigella sativa and albendazole alone and in combination in Toxocara canis infected mice. J Pak Med Assoc 2011; 61 (09) 866-870
  • 58 Humbert P, Niezborala M, Salembier R. , et al. Skin manifestations associated with toxocariasis: a case-control study. Dermatology 2000; 201 (03) 230-234
  • 59 Bardon R, Cuellar C, del Aguila C, Guillen JL. Evaluation of mebendazole activity on experimental murine toxocariasis by immune complexes determination. Zentralbl Veterinarmed B 1995; 42 (04) 235-246
  • 60 Minvielle MC, Basualdo JA, Ciarmela ML, Niedfeld G. Anthelmintic efficacy of tinidazole against the progression of Toxocara canis larvae to the brain in mice. Parasitol Res 1999; 85 (10) 830-832
  • 61 Gónzalez MT, Ibañez O, Balcarce N. , et al. Toxocariasis with liver involvement [in Spanish]. Acta Gastroenterol Latinoam 2000; 30 (03) 187-190
  • 62 Mohamed NH, Soffar SA, Sabry NM, Makled KM, Otifa NM. Effect of immunomodulation on the course of experimental toxocariasis in mice. J Egypt Soc Parasitol 1994; 24 (03) 671-683
  • 63 Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo 2007; 49 (05) 279-287
  • 64 Rüttinger P, Hadidi H. MRI in cerebral toxocaral disease. J Neurol Neurosurg Psychiatry 1991; 54 (04) 361-362
  • 65 Amin HI, McDonald HR, Han DP. , et al. Vitrectomy update for macular traction in ocular toxocariasis. Retina 2000; 20 (01) 80-85
  • 66 Stephanie L. , Harper, Louis JC, Foster CS. Ocular toxocariasis. In: Foster CS, Vitale AT. , eds. Diagnosis and Treatment of Uveitis. Philadelphia, PA: WB Saunders; 2001: 428-436
  • 67 Mora P, Vecchi M, Barbera L, Toscani M, Orsoni JG. Use of systemic cyclosporin A in a case of severe Toxocara uveitis. J Infect 2006; 52 (05) e159-e161